Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: Correlation with clinicopathological features

Clinical Cancer Research

Volumn 4, Issue 6, 1998, Pages 1527-1532

  Yamada, Terumasa ^a   Nakamori, Shoji ^a   Ohzato, Hiroki ^a   Oshima, Satoshi ^a   Aoki, Taro ^a   Higaki, Naozumi ^a   Sugimoto, Keishi ^a   Akagi, Kenzo ^a   Fujiwara, Yoshiyuki ^a   Nishisho, Isamu ^a   Sakon, Masato ^a   Gotoh, Mitsukazu ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE MUTATION; HUMAN; MALE; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PERIPHERAL LYMPHOCYTE; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; BASE SEQUENCE; CHRONIC DISEASE; CODON; DNA; DNA PRIMERS; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATITIS; POINT MUTATION; POLYMERASE CHAIN REACTION; REFERENCE VALUES;

EID: 17344377380     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. American Cancer Society. Cancer facts and figures 1990. Atlanta: American Cancer Society, 1990.
2. Warshow, A. L., and Swanson, R. Pancreatic cancer in 1988: possibilities and probabilities. Ann. Surg., 208: 541-553, 1988.
3. Warshow, A. L., and Castill, C. F. Pancreatic carcinoma. N. Engl. J. Med., 326: 455-465, 1992.
4. Ishikawa, O., Ohigashi, H., Sasaki, Y., Kabuto, T., Fukuda, I., Furukawa, H., Imaoka, S., and Iwanaga, T. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann. Surg., 208: 215-220, 1988.
5. Manabe, T., Ohshio, G., Baba, N., Miyashita, T., Asano, N., Tamura, K., Yamaki, K., Nonaka, A., and Tobe, T. Radical pancreatectomy for ductal cell carcinoma of the head of pancreas. Cancer (Phila.), 64: 1132-1137, 1989.
6. Trede, M., Schwall, G., and Saeger, H. D. Survival after pancreatoduodenectomy. Ann. Surg., 211: 447-458, 1990.
7. Cameron, J. L., Crist, D. W., Sitzman, V., Hruban, R. H., Boitnott, J. K., Seidler, A. J., and Coleman, J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am. J. Surg., 161: 120-125, 1991.
8. Ishikawa, O., Ohigashi, H., Imaoka, S., Furukawa, H., Sasaki, Y., Fujita, M., Kuroda, C., and Iwanaga, T. Preoperative indications for extended pancreatectomy for locally advanced pancreatic cancer involving the portal vein. Ann. Surg., 215: 231-236, 1992.
9. Henne, B. D., Kremer, B., Meyer, P. U., Vogel, I., and Schröder, S. Partial duodenopancreatectomy with radical lymphadenectomy in patients with pancreatic and periampullary carcinomas: initial results. Hepato-Gastroenterology, 40: 145-149, 1993.
10. Connolly, M. M., Dawson, P. J., Michelassi, F., Moosa, A. R., and Lowenstein, F. Survival in 1001 patients with carcinoma of the pancreas. Ann. Surg., 206: 366-373, 1987.
11. Gudjonsson, B. Cancer of the pancreas: 50 years of surgery. Cancer (Phila.), 60: 2284-2302, 1987.
12. Bornman, P. C., Harries, J. E. P., Tobias, R., Stiegmann, G. V., and Terblanche, J. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet, i: 69-71, 1986.
13. Shepherd, H. A., Royle, G., Ross, A. P. R., Diba, A., Arthur, M., and Colin-Jones, D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br. J. Surg., 75: 1166-1168, 1988.
14. Lea, M. S., and Stahlgren, L. H. Is resection appropriate for adenocarcinoma of the pancreas? Am. J. Surg., 154: 651-654, 1987.
15. Tsuchiya, R., Oribe, T., and Noda, T. Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas. Am. J. Gastroenterol., 80: 459-462, 1985.
16. Tsuchiya, R., Tomioka, T., Izawa, K., Noda, T., Yamamoto, K., Tsunoda, T., Harada, N., Yamaguchi, T., Yoshino, R., Mryamoto, T., and Eto, T. Collective review of small carcinomas of the pancreas. Ann. Surg., 203: 77-81, 1986.
17. Mannel, A., Weiland, L. H., van, Heerden, J. A., and Ilstrup, D. M. Factors influencing survival after resection for ductal adenocarcinoma of the pancreas. Ann. Surg., 203: 403-407, 1986.
18. Martin, F. M, Rossi, R. L., Dorrucci, V., Silverman, M. L., and Braasch, J. W. Clinical and pathologic correlations in patients with periampullary tumors. Arch. Surg., 125: 723-726, 1990.
19. Manabe, T., Miyashita, T., Oshio, G., Nonaka, A., Suzuki, T., Endo, K., Takahashi, M., and Tobe, T. Small carcinomas of the pancreas: clinical and pathological evaluations of 17 patients. Cancer (Phila.), 73: 303-320, 1988.
20. Griffin, J. F., Smalley, S. R., Jewell, W., Paradelo, J. C., Reymond, R. D., Hassanein, R. E. S., and Evans, R. G. Pattern of failure after curative resections of pancreatic carcinoma. Cancer (Phila.), 66: 56-61, 1990.
21. Bos, J. L. ras oncogenes in human cancer. Cancer Res., 49: 4682-4689, 1989.
22. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
23. Smit, V. T. H. B., Boot, A. J., Smits, A. M. M., Fleuren, G. J., Cornelisse, C. J., and Bos, J. L. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinoma. Nucleic Acids Res., 16: 7773-7782, 1988.
24. Tada, M., Omata, M., and Ohto, M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology, 102: 233-238, 1991.
25. Hruban, R. H., van Mansfeld, A. D. M., Offerhaus, G. J. A., van Weering, D. H. J., Allison, D. C., Goodman S. N., Kensler, T. W., Bose, K. K., Cameron, J. L., and Bos, J. L. K-ras mutations in adenocarcinoma of the pancreas. Am. J. Pathol., 143: 545-554, 1993.
26. DiGiuseppe, J. A., Hruban, R. H., Offerhaus, G. J. A., Clement, M. J., van den Beig, F. M., Cameron, J. L., and van Mansfeld, A. D. M. K-ras mutations in mucinous pancreatic ductal hyperplasia from a patient with a family history of pancreatic carcinoma. Am. J. Pathol., 144: 889-895, 1994.
27. Tada, M., Omata, M., Kawai, S., Saisho, H., Ohgto, M., Saiki, R. S., and Sninsky, J. J. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res., 53: 2472-2474, 1993.
28. Caldas, C., Hahn, S. A., Hruban, R. H., Redston, M. S., Yeo, C. J., and Kern, S. E. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res., 54: 3568-3573, 1994.
29. Shibata, D., Almoguera, C., Forrester, K., Dunitz, J., Martin, S. E., Cosgrove, M. M., Perucho, M., and Arnheim, N. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res., 50: 1279-1283, 1990.
30. Chen, X. Q., Stroun, M., Magnenat, J. L., Nicod, L. P., Kurt, A. M., Lyautey, J., Lederrey, C., and Anker, P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med., 2: 1033-1035, 1996.
31. Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sindransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med., 2: 1035-1037, 1996.
32. Anker, P., Lefort, F., Vasioukhin, V., Lyautey, J., Lederrey, C., Chen, X. Q., Stroun, M., Mulcahy, H. E., and Farthing, M. J. G. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology, 112: 1114-1120, 1997.
33. Sobin, L. H., and Witekind, C. TNM Classification of Malignant Tumors, Ed. 5, pp. 87-90. New York: Wiley-Liss, 1997.
34. Stroun, M., Anker, P., Lyautey, J., Lederrey, C., and Maurice, P. Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol., 28: 707-712, 1987.
35. Takeda, S., Ichii, A., and Nakamura, Y. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum. Mutat., 2: 112-117, 1993.
36. Tian, F., Appert, H. E., Myles, J., and Howard, J. M. Prognostic value of serum CA19-9 levels in pancreatic adenocarcinoma. Ann. Surg., 215: 350-355, 1992.
37. Leon, S. A., Shapirp, B., Sklaroff, D. M., and Yaros, M. J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res., 37: 646-650, 1977.
38. Carpentier, N. A., Izui, S., Rose, L. M., Lambert, P. H., and Miescher, P. A. The presence of circulating DNA in patients with acute or chronic leukemia: relation to serum anti-DNA antibodies and Clq binding activity. Hum. Lymphocyte Differ., 1: 93-104, 1981.
39. Shapiro, B., Chakrabarty, M., Cohn, E. M., and Leon, S. A. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer (Phila.), 51: 2116-2120, 1983.
40. Sorenson, G. D., Pribish, D. M., Valone, F. H., Memoli, V. A., Bzik, D. J., and Yao, S. L. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomark. Prev., 3: 67-71, 1994.
41. Vasioukhin, V., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., and Stroun, M. Point mutations of the N-ras in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogeneous leukemia. Br. J. Haematol., 86: 774-779, 1994.
42. Hayashi, N., Arakawa, H., Nagase, H., Yanagisawa, A., Kato, Y., Ohta, H., Takano, S., Ogawa, M., and Nakamura, Y. Genetic diagnosis identifies occult lymph node metastasis undetectable by the histopathological method. Cancer Res., 54: 3853-3856, 1994.
43. Hayashi, N., Ito, I., Yanagisawa, A., Kato, Y., Nakamori, S., Imaoka, S., Watanabe, H., Ogawa, M., and Nakamura, Y. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet, 345: 1257-1259, 1995.
44. Sommer, S. S., Groszbach, A. R., and Bottema, C. D. K. PCR amplification of specific alleles (PASA) is a general for rapidly detecting known single-base changes. Biotechniques, 12: 82-87, 1992.
45. Narimatsu, H., Iwasaki, H., Nishihara, S., Kimura, H., Kudo, T., Yamauchi, Y., and Hirohashi, S. Genetic evidence for the Lewis Enzyme, which synthesizes type-1 Lewis antigens in colon tissue, and intracellular localization of the enzyme. Cancer Res., 56: 330-338, 1996.
46. Steinberg, W. M., Gelfand, R., Anderson, K. K., Glenn, J., Kurtzman, S. H., Sindelar, W. F., and Toskes, P. P. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assay in detecting cancer of the pancreas. Gastroenterology, 90: 342-349, 1986.